Welcome

Article

Applied Clinical Trials

Applied Clinical TrialsApplied Clinical Trials-10-11-2005
Volume 0
Issue 0

Welcome to the 12th Annual Applied Clinical Trials European Summit E-Show Daily presented by ACT magazine. This special show daily is designed to give you a recap and highlights of the seminar proceedings and plenary sessions from the conference floor. The conference covered the regulatory climate in Europe and electronic data capture.

Welcome to the 12th Annual Applied Clinical Trials European Summit E-Show Daily presented by ACT magazine.

This special show daily is designed to give you a recap and highlights of the seminar proceedings and plenary sessions from the conference floor. The conference covered the regulatory climate in Europe and electronic data capture.

Articles in this issue
ICTI Software Used in Major Government Study
Special Lecture, Networking Dinner, 5 October 2005: Industry Consolidation and the Emerging Shape of R&D
mdsol_LOGO_LR-185687-1408688434239.jpg
MEDIDATA SOLUTIONS AND CHINESE STATE FOOD & DRUG ADMINISTRATION HOST E-CLINICAL SEMINAR IN BEIJING
accovion200-185732-1408688408788.gif
Seen and Heard
How to Make Progress with Electronic Data Capture, Current and Future Status of EDC in Europe
Successful Development of Vaccines
eResearchTechnology Announces Record-Breaking $32 Million In Third Quarter Awards for Cardiac Safety Monitoring Services and EDC/Clinical Data Technology
Pharmacovigilance in the EU and under the Clinical Trials Directive
Welcome
etrials Adds Three New Trials for Top Ten Pharmaceutical Clients Company Supplies Patient Diary Technology to Over 4,000 New Patients
Updates on the new French health law and it's impact on clinical trials.
New Trends in Outsourcing and Offshoring
Company Enters Funding Transaction to Support Acquisition Strategy and International Growth
wiiliandsteve200-185671-1408688443150.gif
What non-statistitians need to know about statistics
Recent Videos
Related Content
© putilov_denis - © putilov_denis - stock.adobe.com

Understanding Motives Behind Participation in Cancer Clinical Trials

Andy Studna, Senior Editor
January 30th 2025
Article

Recent survey study of 978 cancer patients and their relatives uncovered reasons behind their willingness, or lack thereof, to participate in clinical research.

Reaching Diverse Patient Populations With Personalized Treatment Methods

Reaching Diverse Patient Populations With Personalized Treatment Methods

Andy Studna, Senior Editor
January 20th 2025
Podcast

Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.

Site Logo

New Era of Clinical Trials with oomnia®: Built for Complexity, Designed for Simplicity

Aleksa Jovanovic MD, PhD, Clinical Data and Scientific Content Specialist
January 30th 2025
Article
Our Top 5 Podcast Episodes of 2024

Our Top 5 Podcast Episodes of 2024

Miranda Schmalfuhs
December 27th 2024
Podcast

The top five episodes of our podcast in the year 2024, highlighted.

Credit: magicmine | stock.adobe.com

AZALEA-TIMI 71 Trial Shows Abelacimab Significantly Reduces Bleeding Events vs. Xarelto in AFib Patients

Davy James
January 29th 2025
Article

Abelacimab was found to significantly lower factor XI levels and bleeding events compared to rivaroxaban (Xarelto) in patients with atrial fibrillation at moderate-to-high risk for stroke.

Image credit: luchschenF | stock.adobe.com

Elevidys Shows Continued Promise in Phase III EMBARK Trial for the Treatment of Duchenne Muscular Dystrophy

Andy Studna, Senior Editor
January 28th 2025
Article

In year two of the trial, Elevidys demonstrated statistically significant and clinically improvements across three key functional outcomes.

© 2025 MJH Life Sciences

All rights reserved.